nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Absorptive capacity and disbursements by the Global Fund to Fight AIDS, Tuberculosis and Malaria: analysis of grant implementation
|
Lu, Chunling |
|
2006 |
368 |
9534 |
p. 483-488 6 p. |
artikel |
2 |
AIDS anniversaries in 2006 mark the time to deliver
|
Gayle, Helene D |
|
2006 |
368 |
9534 |
p. 425-427 3 p. |
artikel |
3 |
AIDS: from crisis management to sustained strategic response
|
Piot, Peter |
|
2006 |
368 |
9534 |
p. 526-530 5 p. |
artikel |
4 |
An examination of the Global Fund at 5 years
|
Feachem, Richard GA |
|
2006 |
368 |
9534 |
p. 537-540 4 p. |
artikel |
5 |
Betting on HIV prevention
|
The Lancet, |
|
2006 |
368 |
9534 |
p. 424- 1 p. |
artikel |
6 |
Beyond stigma: social responses to HIV in South Africa
|
Jewkes, Rachel |
|
2006 |
368 |
9534 |
p. 430-431 2 p. |
artikel |
7 |
CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial
|
Ananworanich, Jintanat |
|
2006 |
368 |
9534 |
p. 459-465 7 p. |
artikel |
8 |
Circumcision and HIV prevention research: an ethical analysis
|
Lie, Reidar K |
|
2006 |
368 |
9534 |
p. 522-525 4 p. |
artikel |
9 |
Coordinating HIV control efforts
|
Whyms, Desmond |
|
2006 |
368 |
9534 |
p. 446- 1 p. |
artikel |
10 |
Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials
|
Hicks, Charles B |
|
2006 |
368 |
9534 |
p. 466-475 10 p. |
artikel |
11 |
Ernest Darkoh: confronting the challenge of HIV/AIDS in Africa
|
Kapp, Clare |
|
2006 |
368 |
9534 |
p. 444- 1 p. |
artikel |
12 |
ESPRIT trial
|
Flaherty, Matthew L |
|
2006 |
368 |
9534 |
p. 448- 1 p. |
artikel |
13 |
ESPRIT trial
|
Filippi, Alessandro |
|
2006 |
368 |
9534 |
p. 447-448 2 p. |
artikel |
14 |
ESPRIT trial
|
von Maxen, Andreas |
|
2006 |
368 |
9534 |
p. 448-449 2 p. |
artikel |
15 |
ESPRIT trial
|
O'Donnell, Martin |
|
2006 |
368 |
9534 |
p. 447- 1 p. |
artikel |
16 |
ESPRIT trial – Authors' reply
|
Halkes, PHA |
|
2006 |
368 |
9534 |
p. 449- 1 p. |
artikel |
17 |
Fight AIDS as well as the brain drain
|
Feeley, Frank |
|
2006 |
368 |
9534 |
p. 435-436 2 p. |
artikel |
18 |
HAART for the HIV-infected employees of large companies in Africa
|
Van der Borght, Stefaan |
|
2006 |
368 |
9534 |
p. 547-550 4 p. |
artikel |
19 |
HAART's first decade: success brings further challenges
|
Dore, Gregory J |
|
2006 |
368 |
9534 |
p. 427-428 2 p. |
artikel |
20 |
Heart disease in Africa
|
Opie, Lionel H |
|
2006 |
368 |
9534 |
p. 449-450 2 p. |
artikel |
21 |
HIV/AIDS epidemiology, pathogenesis, prevention, and treatment
|
Simon, Viviana |
|
2006 |
368 |
9534 |
p. 489-504 16 p. |
artikel |
22 |
HIV/AIDS harm reduction in Iran
|
Razzaghi, Emran |
|
2006 |
368 |
9534 |
p. 434-435 2 p. |
artikel |
23 |
HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis
|
|
|
2006 |
368 |
9534 |
p. 451-458 8 p. |
artikel |
24 |
Informing children of their HIV status
|
Nöstlinger, Christiana |
|
2006 |
368 |
9534 |
p. 447- 1 p. |
artikel |
25 |
Microbicides: stopping HIV at the gate
|
Stone, Alan |
|
2006 |
368 |
9534 |
p. 431-433 3 p. |
artikel |
26 |
Persistent pyrexia and plaques: a perplexing puzzle
|
Mosam, Anisa |
|
2006 |
368 |
9534 |
p. 551- 1 p. |
artikel |
27 |
Preventing scientific misconduct
|
Chalmers, Iain |
|
2006 |
368 |
9534 |
p. 450- 1 p. |
artikel |
28 |
Russia's blossoming civil society holds the key to HIV
|
Brown, Hannah |
|
2006 |
368 |
9534 |
p. 437-440 4 p. |
artikel |
29 |
Russia, the G8, and HIV
|
Malinowska-Sempruch, Kasia |
|
2006 |
368 |
9534 |
p. 446- 1 p. |
artikel |
30 |
Scaling up antiretroviral treatment in resource-poor settings
|
Harris, Matthew J |
|
2006 |
368 |
9534 |
p. 445- 1 p. |
artikel |
31 |
Scaling up antiretroviral treatment in resource-poor settings
|
Ellman, Tom |
|
2006 |
368 |
9534 |
p. 445-446 2 p. |
artikel |
32 |
Scaling up antiretroviral treatment in resource-poor settings
|
Batz, Hans-Georg |
|
2006 |
368 |
9534 |
p. 445- 1 p. |
artikel |
33 |
The business of HIV/AIDS
|
The Lancet, |
|
2006 |
368 |
9534 |
p. 423- 1 p. |
artikel |
34 |
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic
|
Montaner, Julio SG |
|
2006 |
368 |
9534 |
p. 531-536 6 p. |
artikel |
35 |
The changing nature of HIV/AIDS in Europe
|
Coker, Richard |
|
2006 |
368 |
9534 |
p. 443- 1 p. |
artikel |
36 |
The devastating effects of HIV/AIDS on children
|
The Lancet, |
|
2006 |
368 |
9534 |
p. 424- 1 p. |
artikel |
37 |
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial
|
Eron Jr, Joseph |
|
2006 |
368 |
9534 |
p. 476-482 7 p. |
artikel |
38 |
The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings
|
Gilks, Charles F |
|
2006 |
368 |
9534 |
p. 505-510 6 p. |
artikel |
39 |
The 10-year struggle to provide antiretroviral treatment to people with HIV in the developing world
|
Schwartländer, Bernhard |
|
2006 |
368 |
9534 |
p. 541-546 6 p. |
artikel |
40 |
Unexpected political immunity to AIDS
|
Kim, Jim Yong |
|
2006 |
368 |
9534 |
p. 441-442 2 p. |
artikel |
41 |
Vaccines to prevent transmission of HIV-1 via breastmilk: scientific and logistical priorities
|
Luzuriaga, Katherine |
|
2006 |
368 |
9534 |
p. 511-521 11 p. |
artikel |
42 |
What does absorption capacity not measure?
|
Bhutta, Zulfiqar A |
|
2006 |
368 |
9534 |
p. 428-430 3 p. |
artikel |
43 |
WHO: strengthening the road to renewal
|
Cohen, Joshua |
|
2006 |
368 |
9534 |
p. 450- 1 p. |
artikel |